184 related articles for article (PubMed ID: 24951429)
1. Fibrinogen γ' increases the sensitivity to activated protein C in normal and factor V Leiden plasma.
Omarova F; Uitte de Willige S; Simioni P; Ariëns RA; Bertina RM; Rosing J; Castoldi E
Blood; 2014 Aug; 124(9):1531-8. PubMed ID: 24951429
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of thrombin-mediated factor V activation contributes to the anticoagulant activity of fibrinogen γ'.
Omarova F; Uitte De Willige S; Ariëns RA; Rosing J; Bertina RM; Castoldi E
J Thromb Haemost; 2013 Sep; 11(9):1669-78. PubMed ID: 23848367
[TBL] [Abstract][Full Text] [Related]
3. Identification and functional characterization of a novel F5 mutation (Ala512Val, FVB onn ) associated with activated protein C resistance.
Pezeshkpoor B; Castoldi E; Mahler A; Hanel D; Müller J; Hamedani NS; Biswas A; Oldenburg J; Pavlova A
J Thromb Haemost; 2016 Jul; 14(7):1353-63. PubMed ID: 27090446
[TBL] [Abstract][Full Text] [Related]
4. Genetic variation in the fibrinogen gamma gene increases the risk for deep venous thrombosis by reducing plasma fibrinogen gamma' levels.
Uitte de Willige S; de Visser MC; Houwing-Duistermaat JJ; Rosendaal FR; Vos HL; Bertina RM
Blood; 2005 Dec; 106(13):4176-83. PubMed ID: 16144795
[TBL] [Abstract][Full Text] [Related]
5. The pleiotropic role of the fibrinogen gamma' chain in hemostasis.
Uitte de Willige S; Standeven KF; Philippou H; Ariëns RA
Blood; 2009 Nov; 114(19):3994-4001. PubMed ID: 19687509
[TBL] [Abstract][Full Text] [Related]
6. The fibrinogen γA/γ' isoform does not promote acute arterial thrombosis in mice.
Walton BL; Getz TM; Bergmeier W; Lin FC; Uitte de Willige S; Wolberg AS
J Thromb Haemost; 2014 May; 12(5):680-9. PubMed ID: 24916154
[TBL] [Abstract][Full Text] [Related]
7. Fibrinogen alpha and gamma genes and factor VLeiden in children with thromboembolism: results from 2 family-based association studies.
Nowak-Göttl U; Weiler H; Hernandez I; Thedieck S; Seehafer T; Schulte T; Stoll M
Blood; 2009 Aug; 114(9):1947-53. PubMed ID: 19515723
[TBL] [Abstract][Full Text] [Related]
8. Thrombosis risk modification in transgenic mice containing the human fibrinogen thrombin-binding gamma' chain sequence.
Mosesson MW; Cooley BC; Hernandez I; Diorio JP; Weiler H
J Thromb Haemost; 2009 Jan; 7(1):102-10. PubMed ID: 18983496
[TBL] [Abstract][Full Text] [Related]
9. Impaired APC cofactor activity of factor V plays a major role in the APC resistance associated with the factor V Leiden (R506Q) and R2 (H1299R) mutations.
Castoldi E; Brugge JM; Nicolaes GA; Girelli D; Tans G; Rosing J
Blood; 2004 Jun; 103(11):4173-9. PubMed ID: 14976057
[TBL] [Abstract][Full Text] [Related]
10. [Activated protein C resistance, Leiden mutation, anticoagulant proteins and fibrinogen levels in patients with deep venous thrombosis].
Jastrzebska M; Bałszan-Kowalska I; Ciechanowicz A; Bińczak-Kuleta A; Falkowski A; Chełstowski K
Pol Arch Med Wewn; 2003 Jun; 109(6):579-88. PubMed ID: 14567090
[TBL] [Abstract][Full Text] [Related]
11. APC resistance: biological basis and acquired influences.
Castoldi E; Rosing J
J Thromb Haemost; 2010 Mar; 8(3):445-53. PubMed ID: 20002539
[TBL] [Abstract][Full Text] [Related]
12. APC-PCI complex concentration is higher in patients with previous venous thromboembolism with Factor V Leiden.
Strandberg K; Stenflo J; Nilsson C; Svensson PJ
J Thromb Haemost; 2005 Nov; 3(11):2578-80. PubMed ID: 16241958
[No Abstract] [Full Text] [Related]
13. Evidence that fibrinogen γ' directly interferes with protofibril growth: implications for fibrin structure and clot stiffness.
Allan P; Uitte de Willige S; Abou-Saleh RH; Connell SD; Ariëns RA
J Thromb Haemost; 2012 Jun; 10(6):1072-80. PubMed ID: 22463367
[TBL] [Abstract][Full Text] [Related]
14. Expression of the normal factor V allele modulates the APC resistance phenotype in heterozygous carriers of the factor V Leiden mutation.
Brugge JM; Simioni P; Bernardi F; Tormene D; Lunghi B; Tans G; Pagnan A; Rosing J; Castoldi E
J Thromb Haemost; 2005 Dec; 3(12):2695-702. PubMed ID: 16359508
[TBL] [Abstract][Full Text] [Related]
15. Genetic modulation of the FV(Leiden)/normal FV ratio and risk of venous thrombosis in factor V Leiden heterozygotes.
Segers O; Simioni P; Tormene D; Bulato C; Gavasso S; Rosing J; Castoldi E
J Thromb Haemost; 2012 Jan; 10(1):73-80. PubMed ID: 22044617
[TBL] [Abstract][Full Text] [Related]
16. Factor V and thrombotic disease: description of a janus-faced protein.
Nicolaes GA; Dahlbäck B
Arterioscler Thromb Vasc Biol; 2002 Apr; 22(4):530-8. PubMed ID: 11950687
[TBL] [Abstract][Full Text] [Related]
17. The effect of fibrin(ogen) on thrombin generation and decay.
Kremers RM; Wagenvoord RJ; Hemker HC
Thromb Haemost; 2014 Sep; 112(3):486-94. PubMed ID: 24964786
[TBL] [Abstract][Full Text] [Related]
18. New functional assays to selectively quantify the activated protein C- and tissue factor pathway inhibitor-cofactor activities of protein S in plasma.
Alshaikh NA; Rosing J; Thomassen MCLGD; Castoldi E; Simioni P; Hackeng TM
J Thromb Haemost; 2017 May; 15(5):950-960. PubMed ID: 28211163
[TBL] [Abstract][Full Text] [Related]
19. Thrombin-activatable fibrinolysis inhibitor antigen and TAFI activity in patients with APC resistance caused by factor V Leiden mutation.
Antovic JP; Blombäck M
Thromb Res; 2002 Apr; 106(1):59-62. PubMed ID: 12165290
[TBL] [Abstract][Full Text] [Related]
20. Effects of hereditary and acquired risk factors of venous thrombosis on a thrombin generation-based APC resistance test.
Curvers J; Thomassen MC; Rimmer J; Hamulyak K; van der Meer J; Tans G; Preston FE; Rosing J
Thromb Haemost; 2002 Jul; 88(1):5-11. PubMed ID: 12152677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
